Trazodone was approved as an antidepressant, but its most common side effect — excessive daytime sleepiness in ~50% of patients — launched a second career. At 50–100 mg off-label, a 2022 meta-analysis confirmed it increases total sleep time and actually increases slow-wave sleep rather than suppressing it, making it one of the most rational long-term sleep medication options available.